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Probiotics are live microorganisms used as supplementary food, usually lactic acid bacteria that 
can change either the composition and/or the metabolic activities of the gut microbiota modulating 
the immune system in a way that benefits the person’s health. 
Aim: to review the use of Probiotics (Lactobacillus and Bifidobacterium) in allergic rhinitis patients. 
Materials and Methods: Pubmed original articles were used as data source. 
Results: results indicate that probiotics, Lactobacillus and Bifidobacterium appear to prevent allergy 
recurrences, alleviate the severity of symptoms and improve the quality of life of patients with 
allergic rhinitis. This happens because of the immune system modulation through the induction of 
cytokine production which cause a dominant TH1 response in allergic patients by modulating the 
TH1/TH2 balance effect. 
Conclusion: The use of probiotic bacteria could be an effective and safe way to prevent and/
or treat allergic rhinitis, but its underlying mechanisms remain unclear. Therefore, clinical studies 
using probiotics and dietary intervention should be the focus of future research to enable a more 
widespread use.
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INTRODUCTION
Allergic rhinitis is a nasal inflammatory disease 
which manifests when a sensitized individual comes in 
contact with foreign substances, called antigens. It is very 
frequent in today’s world, affecting individuals of both 
genders and all ages. It may manifest from mild symptoms 
to symptoms which reduce the individual’s quality of life 
and productivity, either in a temporary or permanent basis 
when there is not proper treatment1.
Today, both in developed countries as well as in 
those developing ones, we notice a different disease profile 
when compared to that of previous decades, with a predo-
minance of allergic, autoimmune and chronic inflammatory 
diseases instead of their infectious counterparts. Part of 
this phenomenon is due to the “Hygiene Hypothesis”, ac-
cording to which changes in the life styles of people, such 
as in food, consumption of industrialized products rich in 
preservatives and other chemical products, as well as the 
reduction of contact children would have with microorga-
nisms because of better hygiene and vaccination, brought 
about changes to the individuals’ immune characteristics2.
When a foreign substance comes in contact with 
the body, it is phagocyted and processed by the antigen-
presenting cells. These cells expose this antigen on its 
membrane, with its histocompatibility complex (HLA) 
- class II, which, when it interacts with the receptor on 
the T CD4+ cell membrane promotes the proliferation of 
a specific clone of type 1 or type 2 T helper cells, which 
according to the secreted cytokines will enable a type of 
immune reaction3.
The T helper 1 cells produce TNF Beta (Tumor 
Necrosis Factor) and Interferon C which activates the cells 
involved in cell immunity, in other words, on the body’s 
defense against intracellular organisms such as viruses and 
other microorganisms which infect the inside of the cell, 
defective and cancer cells. The T helper 2 cell line produce 
IL-4, IL-5, IL10, IL13 which stimulate cells to participate 
in the allergic reaction, such as IgE secreting B cells, mast 
cells and eosinophils4.
According to some authors, what would explain the 
“Hygiene Hypothesis” would be a higher predominance 
of the Th2 cell line in comparison to the Th1, where the 
change in intestinal microbiota can be one of the factors 
involved5.
Studies have shown that the bacteria present in the 
intestinal micro flora play a role in the Th1/Th2 balance, 
and its modulation can promote the control of infectious 
and immune processes. This modulation can be carried out 
through the use of probiotics, which are supplements of 
microorganisms. The probiotics concept has been around 
for more than 100 years. Between the XIX and XX centu-
ries, Moro isolated Lactobacillus in the feces from infants 
fed maternal milk, and Tissier found the bifidobacteria; in 
the early XX century, Metchnikoff reported the high lon-
gevity of Bulgarian peasants who drank fermented milk, 
and such product is today recommended by the World 
Health Organization2.
The main probiotics are Lactobacillus acidophilus, 
Lactobacillus casei, Lactobacillus plantarum, Lactoba-
cillus reuteri, Lactobacillus rhamnosus, Lactobacillus 
paracasei, Bifidobacterium bifidum, Bifidobacterium 
breve, Bifidobacterium infantis, Bifidobacterium lactis, 
Bifidobacterium longum, Bifidobacterium adolescentis, 
Saccharomyces bourlardii, Propionibacterium freuden-
reichii; and also Escherichia, Enterococcus and Bacillus 
and the Saccaromyces boulardii fungus. Notwithstanding, 
despite being beneficial to the body and being frequently 
added to children food, the Lactobacillus bulgaricus and 
Streptococcus thermophilus are not considered probiotics2.
In order for a probiotic agent to be satisfactory, the 
component bacteria must be natural dwellers of the GI 
tract, must be resistant to gastric secretions and bile, have 
a precise taxonomic identification, colonize the intestinal 
mucosa, be active in the food before its consumption and 
be continuously ingested. Its minimum dose is 106 UFC6.
Studies have assessed the benefits of using probio-
tics to manage allergies in improving the function of the 
native intestinal microbiota6. Based on these facts, this 
bibliographic review aimed at assessing the importance 
of using probiotics in allergic rhinitis through reading the 
scientific literature indexed in the Pubmed between the 
years of 2000 and 2008.
MATERIALS AND METHODS
This study is a bibliographic review on the topic of 
probiotic and allergic rhinitis. The source of the informa-
tion used was the Pubmed database, between 2000 and 
2008. We included preferably clinical trials, meta-analyses 
and review papers in Portuguese, English and Spanish, as 
well as papers which topic discussed was the clinical or 
experimental use of Lactobacillus and Bifidobacterium 
on allergic rhinitis, and we took off those studies concer-
ning other sources of allergy. The keywords used in the 
respective languages were: “probiotics, allergic rhinitis, 
Lactobacillus, Bifidobacterium”.
When the keyword Bifidobacterium was studied, 
1963 papers were found, increasing the number to 7012, 
when the keyword used was Lactobacillus. These findings 
suggest a great interest in probiotics, especially concerning 
Lactobacillus, very likely because of its broad use as food 
supplement and because of the growing interest in its use 
for health promotion purposes. When we cross-referenced 
rhinitis and Lactobacillus keywords, rhinitis and Bifidobac-
terium and rhinitis and probiotics, these figures decrease 
to 26, 10 and 46 papers, respectively.
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LITERATURE REVIEW
The intestinal barrier is our strongest body barrier 
against microorganisms and foreign substances. Disorders 
in the intestinal microbiota change the permeability and 
reduce the intestinal selectivity to macromolecules, and 
such phenomenon is known as “leaky gut,”. Probiotics 
can reinforce the intercellular junctions in the GI tract, 
making the intestine “less leaky” - as well as increasing 
the cytokines which stimulate lymphocytes of the Th1 
line, reestablishing oral tolerance and reducing the allergic 
response7,8. Then, it is understood that the intestinal flora 
make up is important in the immune response balance.
A study assessing children from countries of low 
incidence of allergic diseases, compared to children from 
countries of low incidence of these diseases, showed that 
there were differences in the intestinal flora makeup of 
the children with a predominance of Clostridium and S. 
aureus in the former and Lactobacillus, Bifidobacteria and 
Enterococos in the latter9.
Numerous studies have reported on the antiallergic 
activity of Lactobacilli, with only a few studies involving 
Bifidobacteria, and such activity was specific for species 
concerning both bacteria. However, what one can notice 
in these studies is that both the probiotics of the Lacto-
bacillus genus as the Bifidobacterium suppressed the 
allergic response, promoting modulation and regulation 
of the immune system10.
Aldinucci et al., 2002, investigated 20 volunteers: 13 
with allergic rhinopathy and 7 healthy individuals - who 
made up the control group, concerning the effects of con-
suming yogurt with Lactobacillus delbruekii, sub bulgaricus 
and Streptococcus thermophiles for four months, in other 
words two types of probiotic agents: one Lactobacillus 
acidophilus and one bifidobacterium or skim milk. Of the 
13 individuals, 7 received 450g of yogurt and 6 were given 
450g of partial skim milk, and the regular nutrition was 
maintained. We assessed the following parameters before 
and after: rate of mononuclear cell proliferation and its 
release of Interferon Gama (INF- γ) and Interleukin 4 (IL-
4). In order to assess allergic rhinopathy, we used nasal 
function tests (anterior rhinometry, acoustic rhinometry), 
the Prick test, specific nasal provocation test (NPT), dosage 
of specific IgE in the blood, assessment of symptoms and 
nasal mucociliary transport test. The patients who were 
fed yogurt had improvements in their symptoms and in 
nasal mucociliary transport, and the other parameters 
remained unaltered; as far as cell culture goes, there was 
a reduction in IL-4 secretion and more TNF-γ secretion; 
without changes to the proliferation rate. According to the 
authors, these findings indicate a beneficial effect of using 
this type of foods stuff10.
The dendritic cells are considered the most efficient 
antigen-presenting cells, with an important participation 
in the onset of the primary immune response and in the 
development of the secondary response. These cells can 
be modulated by the probiotic agents and this could be 
possible due to specific membrane receptors called “toll-
like” for the bacteria. Christensen et al., 2002, showed that 
different species of Lactobacillus cause different forms of 
activation of the dendritic cells11.
Kimoto et al., 2004, carried out a study in order to 
assess the immune modulatory activity of 15 strains of Lac-
tobacillus. Initially, they carried out an in vitro assessment 
of the cytokine induction capacity of murine macrophages 
of the J774 line in culture. In this experiment, 6 strains of 
Lactobacillus induced the production of IL2, IL6, TNF-α 
in a species-specific mode. Of these strains, G50 was the 
one that most induced cytokine, thus being isolated for 
further studies. They also analyzed the cytokine-induction 
capacity of macrophages in culture, induced by strains 
of L. lactis subsp. Lactis G50 killed by heat to assess its 
activity even in the unfeasible form. It was observed that 
this strain continued to induce cytokine production, sug-
gesting that such activity is associated with elements on 
the bacterial wall. We can also notice that the unfeasible 
forms stimulated a greater production of IL12 and lower 
of IL6, when compared to feasible strains12.
The same authors assessed the In vivo activity of the 
G50 strain of Lactobacillus taken orally during 7 days, by 
BALB/c mice and later on analyzed its spleen cells, and 
they observed a growth in the synthesis of IL12 and inter-
feron Gama and mild reduction of IL4 and IL6, in relation 
to controls. The effect of Lactobacillus, in the production 
of In vivo antibodies, was also studied in the immuniza-
tion of mice with OVM (ovomucoid) measuring the level 
of antibodies in the plasma. The specific IgE rate for the 
antigen used (OVM) in the serum of those who received 
Lactobacillus G50 caused a significant reduction (p<0.01) 
in comparison to the controls, as well as that of IgG 1, 
immunoglobulins involved in the allergic processes, not 
having changes to IgG2a - not involved in these processes. 
When the spleen cells of OVM sensitized mice with this 
antigen were incubated with this antigen and later on they 
measured the amount of OVM-IgE in the supernatant, they 
noticed that in the mice receiving Lactobacillus per os 
there was a significant reduction of specific IgE without, 
however, causing changes to the IL levels. These findings 
suggest that the use of Lactobacillus, specifically of the L. 
lactis subsp. Lactis G50 strain, promoted a stimulation of 
the Th1 line instead of in the Th2, and this is important 
to consider in the modulation of allergic conditions, since 
the immune status of humans is closely related to the Th1/
Th2 balance.
Rosenfeldt et al., 2003, reported that there were no 
significant differences as to the severity of atopic derma-
titis in children with overt dermatitis when they used L. 
rhamnosus and L. reuteri for 6 weeks when compared to 
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placebo; nonetheless, analyzing the atopic child with a 
positive prick test and high IgE level there was a reduction 
in severity, as well as in the levels of cationic eosinophilic 
protein levels, but without changing the levels of IL-2, IL-4, 
IL-10 and interferon γ, concluding that there was a positive 
effect concerning the use of a probiotic13.
Peng; Hsu, 2005, carried out a study using strain 
LP33 Lactobacillus paracasi, heat-neutralized, assessing its 
effects on the improvement of the quality of life of patients 
with allergic rhinitis induced by house dust. Based on a 
modified questionnaire of pediatric rhino-conjunctivitis 
associated with quality of life, and they observed that this 
means of use was as efficient as the administration of live 
forms, in quality of life improvements14.
Xiao et al., 2006, assessed the use of Bifidobacte-
rium longum BB536 during 13 weeks in the evolution of 
pollinosis from Japanese cedar and, based on the parame-
ters evaluated, they noticed that the use of these probiotic 
agents did not only improve symptoms, but it also caused 
a reduction in the TH2 response instead of an increase in 
TH1 response15.
Takahashi et al., 2006, assessed a sequence of DNA 
nucleotides from the Bifidobacterium longum, BB 536 
strain probiotic, which inhibited the in vitro production 
of IgE and it also stimulated the proliferation of B cells, 
induced the production of IL-12 in a culture of J774.1 and 
macrophage murine increased the secretion of interferon-
Gama, without however having an effect on IL416,17.
Showing a protective effect of probiotics in allergy, 
Morita et al., 2006, utilized fermented milk with TMC0356 
Lactobacillus gasseri in 15 individuals with high serum IgE 
and allergic rhinitis, in the dose of 200ml/day during 4 
weeks and observed a significant decline (p<0.05) in the 
total IgE serum levels, as well as specific IgE for mite and 
Japanese cedar pollen, after 28 days of exposure compared 
to the baseline value; besides these findings, there was an 
increase in the number of TH1 cells18.
The Japanese cedar pollinosis is an IgE-mediated 
type I allergic reaction, caused by the exposure to Cryp-
tomeria japonica, Japanese cedar or Japanese araucaria, 
which affects 16% of the Japanese population, currently 
being considered a public health problem in that country19.
Ogawa et al., 2006, studied the development of 
skin lesions similar to that of atopic dermatitis in NC/Nga 
mice with clinical symptoms and blood parameters which 
are characteristic of allergic rhinitis in healthy volunteers 
during the time of pollination in Japan by the Cryptomeria 
japonica, concurrent to the oral administration of a sym-
biotic combination of Lactobacillus casei subsp. casei plus 
dextran, and they noticed that there was an improvement 
in the skin lesions, although without significant changes as 
far as the allergic rhinitis goes in these animals. Assessing 
those patients who used placebo, they observed that there 
was a trend towards an increase in the levels of specific 
IgE for this pollen, as well as of cytokines and eosinophils 
and reduction in the levels of interferon Gama in relation 
to the individuals who used the probiotic, concluding 
that, in a certain way, the use of such association helped 
the individuals have a satisfactory response to rhinitis20.
In 2007, Odamaki et al. carried out a clinical trial 
to assess the effects of BB 536 Bifidobacterium longum-
enriched in the treatment of Japanese cedar pollinosis and 
observed that, during the pollination period, the concomi-
tant use of probiotics helped alleviate the symptoms, while 
the raise in serum levels of eosinophils and a reduction in 
INFγ were suppressed19.
In a new study carried out in 2007, Odamaki et al. 
observed that, during the pollination period, there was 
a change in the intestinal microbiota of the individuals, 
when compared to non-allergic individuals, especially 
concerning Bacteroides fragillis, and the use of a probio-
tic inhibited this fluctuation, preserving the proper micro 
flora. The microbiota fluctuation in this study was seen in 
allergic individuals at the beginning and at the end of the 
pollination phase, without a concrete scientific explana-
tion, speculating that this could have happened because 
of the stress caused by these symptoms21.
Iwabuchi et al., 2007, studied 17 strains of lactic 
acid bacteria and 15 of bifidobacteria and observed that in 
relation to the production of IL12, the former were more 
efficient. According to the study, the Bifidobacterium lon-
gum BB536 strain inhibited IL-4 and antigen-specific IgE 
production, partially independent of the Th1 line cytokines 
and independent of regulatory cytokines with IL-12, IL10 
and TNF-β, which are measured by the antigen-presenting 
dendritic cells. They also observed that the BB536 stimu-
lated the maturation of dendritic cells, especially after 
antigen stimulation and which inhibited the TH2 immune 
response in T memory lymphocytes22.
Sunada et al., 2007, assessed the effects of Lac-
tobacillus acidophilus L-55 strain in BALB/c mice, with 
experimental allergic rhinitis and observed that the use 
of 10mg/day for 4 consecutive weeks resulted in reduced 
nasal sensitization, the frequency of sneezing after the 
second week of use, and the control medication reduced 
these symptoms only on the fourth week. There was also 
a significant reduction in the specific IgE dosing for OVA 
(ovalbumin), at the end of 4 weeks, indicating that the 
administration of L-55 strains of Lactobacillus inhibited the 
IgE production in sensitized mice23.
Kawase et al., 2007, used the TMC 0356 strain of 
Lactobacillus gasseri and GG Lactobacillus in guinea pigs 
sensitized by the Japanese Cedar pollen, in the dose of 
103 CFU during 3 weeks, with the goal of assessing the 
presence of nasal obstruction induced by the intranasal 
administration of OVA and changes to the immune cells 
of the nasal lavage and observed that, in relation to air 
flow resistance, after nasal administration of Ovalbumin, 
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there was an increase in the resistance in both guinea 
pigs; however, in those who received Lactobacillus, this 
resistance was lower when compared to the control group 
after 10 minutes of OVA administration, and these data 
were statistically significant. In relation to the cells, there 
was a reduction in the number of leucocytes, especially 
eosinophils and neutrophils, in the nasal lavage and serum 
reduction in the levels of specific OVA-IgE levels and, 
despite this data not being significant in the study, they 
suggest a considerable action of these Lactobacillus, thus 
requiring further studies for such confirmation24.
Rasche et al., 2007, co-stimulated peripheral mono-
nuclear cells of individuals allergic to grass pollen (n=10) 
and those non-allergic (n=19) with inactive Lactobacillus 
acidophilus and the non-pathogenic Nissle strain of Es-
cherichia coli and observed that both bacteria modulated 
the immune response from changes to the CD23 and 
expression of co-stimulatory molecules. In relation to the 
production of cytokines, there was a response depending 
on the presence or not of atopy; however there is an in-
crease in the Th1 cells of atopic individuals25.
A lysate of Enterococcus faecallis FK-23 (LFK), a 
probiotic product of E faecallis, showed an inhibitory 
effect on the local buildup of eosinophils induced by 
allergens in active skin anaphylaxis in rat models. By the 
same token, a pilot clinical study in humans showed that 
the number of eosinophils in the peripheral blood was 
significantly reduced after treatment with LFK in patients 
with permanent allergic rhinitis. Therefore, it has been 
suggested that LFK supplementation can play a role in 
the prevention and/or in the Th2 predominance transfer 
to a Th1/Th2 balance26.
Considering the above, Shimata et al., 2007, investi-
gated the effects of using oral antibiotics in weaned mice, 
and the influence of oral consumption either associated 
or not to LFK (FK-23 Enterococcus faecallis lysate) on the 
local buildup of allergy-induced eosinophils, the levels 
of total IgE, antigen-specific IgE and IgG2a in the serum 
and on the intestinal micro flora. For the study they used 
3-week-old Balb/Cmice sensitized with the allergen (Ja-
panese Cedar pollen) experimental model and treated 
with macrolide and macrolide + Enterococcus faecallis 
FK-23 (LFK) lysate and observed that the Lactobacilli 
species were distinctly eliminated in the mice exposed to 
erythromycin on the 7th day and totally recovered in the 
mice treated with LFK-erythromycin on the 28th day, but 
not found on the mice which used erythromycin without 
LFK. They did not observe a statistically significant diffe-
rence between the mice with and without LFK in terms 
of peritoneal buildup of eosinophils and specific serum 
IgE and IgG2a; however, in the total IgE and IgG2a ratio, 
there was a significant increase in the mice which used 
erythromycin only when compared to those who used 
LFK 26.
Giovannini et al., 2007, assessed the benefits of a 
prolonged use, 12 months, of fermented milk, with one 
species of Lactobacillus casei in 187 children between 
2 and 5 years with allergic rhinitis and/or asthma, and 
observed that there was a significant improvement in the 
number of rhinitis episodes per year; however, without 
change on the asthma evolution27.
Kuitunen et al., 2008, administered a mixture of 
probiotics (Lactobacilllus, Bifidobacteria and Propioni-
bacteria) or placebo in pregnant women in the last ges-
tational months and in their babies, with a high risk of 
allergy, up to 6 months of life, and these children were 
evaluated at 5 years of age. The authors did not find sta-
tistically significant differences concerning the incidence 
of allergic diseases such as eczema, rhinitis, asthma and 
food allergies in the group receiving probiotics who were 
born out of c-sections28.
Dev et al., 2008, evaluated the action of Lac-B, 
which is a mix of Bifidobacterium infantis and Bifidobac-
terium longum dried-frozen, on the release of histamine in 
a dry experimental model  with rats with allergic rhinitis 
and observed that the use of these acid bacteria promo-
ted a reduction in the expression of H1 receptors on the 
mucosa as well as RNAm expression of the decarboxylase 
histidine, reducing the release and action of histamine and 
alleviating the allergic symptoms. In this study the pre-
treatment with Lac-B also reduced RNAm expression of 
IL-4 and IL-5 without; however, being statistically signifi-
cant when compared to the control individuals. This data 
reinforce the action of these bacteria on the inhibition of 
the cytokines responsible for the allergic reaction.29
Vliagoftis et al., 2008, carried out a review study 
using Pubmed database on the use of probiotics in the 
treatment of allergic rhinitis and asthma, and they obser-
ved that its use reduce the severe forms of allergic rhinitis 
and reduce the use anti-allergic drugs, without studies 
which show a satisfactory response as far as asthma is 
concerned30.
Ivory K et al., 2008 observed through a double-
blind placebo-controlled study that the five-month use 
of Lactobacillus casei Shirota (LcS) caused a significant 
reduction in the levels of antigen-induced IL-5 and IL-6 
and interferon Gama (IFN-γ) compared to placebo and 
IgG increase without impact on IgE reduction31.
DISCUSSION AND CONCLUSION
Despite significant studies, very little is known about 
the use of these substances and the effects of extrinsic 
factors which would change the intestinal microbiota and 
promote diseases - allergic rhinitis among them.
Since allergic rhinitis remains a constant challenge 
for physicians, it is necessary to search for new treatment 
alternatives which could improve the quality of life of 
patients, and probiotics could represent a promising al-
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ternative. Nonetheless, more encompassing studies, with 
more patients, need to be carried out, in such a way that 
probiotics can be fully used, enabling a better treatment 
approach with benefits for the patients.
All these studies showed that probiotics promote an 
improvement to the immune response of the human body, 
and we noticed a satisfactory action on the modulation of 
the allergic response.
Based on probiotics and allergic rhinitis studies, we 
may conclude that the use of these substances brought 
about a satisfactory response in symptom control, better 
quality of life and lab markers both in vitro and in vivo.
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